Subscribe to RSS
DOI: 10.1055/s-0044-1779676
Corrigendum: Implications of Ozempic and Other Semaglutide Medications for Facial Plastic Surgeons
![](https://www.thieme-connect.de/media/fps/202306/lookinside/thumbnails/10-1055-s-0044-1779676_2023070123oacorrigendum-1.jpg)
The above article published in Facial Plastic Surgery in Volume 39, Number 6, 719-721, in December 2023 (DOI: 10.1055/a-2148-6321), has been revised to better reflect its focus on the impact GLP-1 receptor agonists have on facial plastic surgeons and their patients. It is not intended to promote the use of GLP-1 receptor agonists for anything other than its FDA-approved use. It is important for facial plastic surgeons to understand the intended use and mechanism of action of these medications and how they may affect the physiology and facial aesthetics of their patients. The article has been updated to reflect the same.
Publication History
Article published online:
11 April 2024
© 2024. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA